ImCheck Therapeutics vs Lexeo Therapeutics
ImCheck Therapeutics vs Lexeo Therapeutics, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: ImCheck Therapeutics is on 60/100 and Lexeo Therapeutics on 61/100.
Where each one leads
ImCheck Therapeutics
Leads on none of the measures we hold for both companies.
Lexeo Therapeutics
- agent readiness: 40/100 against 34/100
- headcount: 91 against 47
- funding raised: $495M against $164M
- LinkedIn following: 16,654 against 11,647
At a glance
| Measure | ImCheck Therapeutics | Lexeo Therapeutics |
|---|---|---|
| What it is | ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies. | Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Biotech | Platform |
| Founded | 2015 | 2020 |
| Headquarters | Marseille, France | New York City, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | ImCheck Therapeutics | Lexeo Therapeutics |
|---|---|---|
| Employees | 47 | 91 |
| Total funding | $164M | $495M |
| Latest round | Not published | Public Offering |
| LinkedIn followers | 11,647 | 16,654 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | ImCheck Therapeutics | Lexeo Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 61/100 |
| Traction | 57/100 | 60/100 |
| Team | 70/100 | 70/100 |
| Community | 15/100 | 8/100 |
| Search visibility | 22/100 | 28/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (34/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 37/100 | 41/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | ImCheck Therapeutics | Lexeo Therapeutics |
|---|---|---|
| Hosting | Self Managed | Self Managed |
| CMS | Not detected | WordPress |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Jquery |
| Analytics | Google Analytics 4 | Google Tag Manager |
ImCheck Therapeutics vs Lexeo Therapeutics: common questions
Which is better, ImCheck Therapeutics or Lexeo Therapeutics?
On our 0-100 score Lexeo Therapeutics rates higher (61/100 against 60/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.
How do ImCheck Therapeutics and Lexeo Therapeutics compare on the numbers?
Lexeo Therapeutics leads on agent readiness (40/100 against 34/100), headcount (91 against 47), funding raised ($495M against $164M), LinkedIn following (16,654 against 11,647).
Read the full ImCheck Therapeutics review and pricing or the Lexeo Therapeutics review and pricing. You can also browse other ImCheck Therapeutics alternatives we track.